Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study

Drug safety is generally established from clinical trials, by pharmacovigilance programs and during observational phase IV safety studies according to drug intended or approved indications. The objective of this study was to estimate the risk of potential adverse drug events (ADEs) associated with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Matt K., Bikmetov, Ravil, Al Rihani, Sweilem B., Deodhar, Malavika, Hafermann, Matthew, Dow, Pamela, Turgeon, Jacques, Michaud, Veronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251090/
https://www.ncbi.nlm.nih.gov/pubmed/33786990
http://dx.doi.org/10.1111/cts.13025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251090/
https://www.ncbi.nlm.nih.gov/pubmed/33786990
http://dx.doi.org/10.1111/cts.13025

Ejemplares similares